This week we sit down virtually with Dr. Atle Fretheim, Research Director of the Norwegian Institute of Public Health, to talk about how Norway has responded to the COVID-19 crisis – specifically, how they’ve handled it when it comes to public schools. We also have an interview with Dr. Anthony “Tony” Letai of the Dana Farber Cancer Center on cancer biology. Back us on Patreon!…
U.S. marriage rates have plummeted. But the babies keep coming, and the U.S. now leads the world in single-parent households. In her new book “The…
The first CRISPR gene-editing treatment is a cure for sickle cell disease. Are we on the cusp of a gene therapy revolution?
If it succeeds—and that is no sure thing—this week’s soft landing of Odysseus will be the first by a private firm. We examine the prospects…
TESTING is the latest IgA nephropathy trial and it is the comeback kid of nephrology trials. From a trial that was halted because of excess…
TESTING is the latest IgA nephropathy trial and it is the comeback kid of nephrology trials. From a trial that was halted because of excess…
In Season 2 of the NEJM podcast “Not Otherwise Specified” (NOS), host Lisa Rosenbaum delves into multiple facets of a burgeoning revolution in medical training.…
Core IM | Internal Medicine Podcast January 17, 2024
U.S. marriage rates have plummeted. But the babies keep coming, and the U.S. now leads the world in single-parent households. In her new book “The…
Michael S. Bryant, our guest this week, is a professor of history and legal studies specializing in the impact of the Holocaust. He’s based at…
In this episode, Anthony and Bernie are joined by two very special guests – Dr. Aaron “Papa Heme” Goodman and Dr. Manni “Myeloma Man” Mohyuddin…
